A novel mutation associated with Type III Bartter syndrome: A report of five cases

Li,Yanhan; Wu,Chengcheng; Gu,Jie; Li,Dong; Yang,Yanling

doi:10.3892/mmr.2019.10255

A novel mutation associated with Type III Bartter syndrome: A report of five cases

Authors:
- Yanhan Li
- Chengcheng Wu
- Jie Gu
- Dong Li
- Yanling Yang
View Affiliations

Affiliations: Department of Laboratory Animal Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, P.R. China, Department of Cardiology, General Hospital of Tianjin Medical University, Tianjin 300052, P.R. China, Department of Nephrology, General Hospital of Tianjin Medical University, Tianjin 300052, P.R. China, Department of Pediatrics, Peking University First Hospital, Beijing 100034, P.R. China
Published online on: May 16, 2019 https://doi.org/10.3892/mmr.2019.10255
Pages: 65-72

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The clinical, biochemical and mutation spectra of Chinese patients with Type III Bartter syndrome (type III BS), a rare autosomal recessive disorder, were investigated. A total of five unrelated Chinese patients aged 8 months to 24 years were diagnosed with type III BS via analysis of biochemical markers, including chloride, potassium and calcium, and genetic sequencing. The levels of insulin‑like growth factor‑1 (IGF‑1) were evaluated via ELISA and a mutation study of cultured amniocytes was conducted for prenatal diagnosis. The child patients were admitted for polydipsia, polyuria, myasthenia and developmental delay, whereas the adult patients were hospitalized for limb numbness, polydipsia and polyuria. Nine variants in the chloride voltage‑gated channel Kb (CLCNKB) gene were detected, including eight sequence variants and one whole CLCNKB gene deletion. One sequence variant (c.1967T>C) was novel, whereas the remaining variants (c.595G>T, c.908A>C, c.1004T>C, c.1312C>T, c.1334_1335delCT and c.1718C>A) and the whole gene deletion had been previously reported. The whole gene deletion was frequently observed in patients with early‑onset type III BS in the present study. Two patients showed IGF‑1 deficiency with normal growth hormone level. All patients were treated with potassium supplementation and indometacin. The mother of one patient underwent amniocentesis during her second pregnancy; the fetus was not affected by type III BS based on screening for sequence variants, and normal development and blood electrolyte analysis following birth confirmed the diagnosis. In conclusion, five cases of type III BS in patients from mainland China were reported. Large deletions were frequently detected, particularly in early‑onset patients; isolated IGF‑1 deficiency was found, one novel sequence variant was identified. Prenatal diagnosis was successfully established using genetic analysis of cultured amniocytes, and may facilitate the prevention of congenital defect of type III BS in the next pregnancy.

View Figures

View References

1	Cunha TDS and Heilberg IP: Bartter syndrome: Causes, diagnosis, and treatment. Int J Nephrol Renovasc Dis. 11:291–301. 2018. View Article : Google Scholar : PubMed/NCBI
2	Bartter FC, Pronove P, Gill JR Jr and Maccardle RC: Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. Am J Med. 33:811–828. 1962. View Article : Google Scholar : PubMed/NCBI
3	Madrigal G, Saborio P, Mora F, Rincon G and Guay-Woodford LM: Bartter syndrome in Costa Rica: A description of 20 cases. Pediatr Nephrol. 11:296–301. 1997. View Article : Google Scholar : PubMed/NCBI
4	Abdel-al YK, Badawi MH, Yaeesh SA, Habib YQ, al-Khuffash FA, al-Ghanim MM and al-Najidi AK: Bartter's syndrome in Arabic children: Review of 13 cases. Pediatr Int. 41:299–303. 1999. View Article : Google Scholar : PubMed/NCBI
5	Rudin A: Bartter's syndrome. A review of 28 patients followed for 10 years. Acta Med Scand. 224:165–171. 1988. View Article : Google Scholar : PubMed/NCBI
6	Estévez R and Jentsch TJ: CLC chloride channels: Correlating structure with function. Curr Opin Struct Biol. 12:531–539. 2002. View Article : Google Scholar : PubMed/NCBI
7	Fulchiero R and Seo-Mayer P: Bartter syndrome and gitelman syndrome. Pediatr Clin North Am. 66:121–134. 2019. View Article : Google Scholar : PubMed/NCBI
8	Lopez HU, Haverfield E and Chung WK: Whole Exome sequencing reveals CLCNKB mutations in a case of sudden unexpected infant death. Pediatr Dev Pathol. 18:324–326. 2015. View Article : Google Scholar : PubMed/NCBI
9	Rodriguez-Soriano J, Vallo A, Pérez de Nanclares G, Bilbao JR and Castaño L: A founder mutation in the CLCNKB gene causes Bartter syndrome type III in Spain. Pediatr Nephrol. 20:891–896. 2005. View Article : Google Scholar : PubMed/NCBI
10	Han Y, Lin Y, Sun Q, Wang S, Gao Y and Shao L: Mutation spectrum of Chinese patients with Bartter syndrome. Oncotarget. 8:101614–101622. 2017. View Article : Google Scholar : PubMed/NCBI
11	World Medical Association: World medical association declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 79:373–374. 2001.PubMed/NCBI
12	Xiumin W, Zheng S, Meichun X, Junfen F and Li L: A Chinese Girl with Bartter syndrome type III due to a novel mutation and/or single nucleotide polymorphisms (SNPs) in CLCNKB Gene. Iran J Pediatr. 23:89–94. 2013.PubMed/NCBI
13	Srebniak M, Boter M, Oudesluijs G, Joosten M, Govaerts L, Van Opstal D and Galjaard RJ: Application of SNP array for rapid prenatal diagnosis: Implementation, genetic counselling and diagnostic flow. Eur J Hum Genet. 19:1230–1237. 2011. View Article : Google Scholar : PubMed/NCBI
14	Saito-Ohara F, Uchida S, Takeuchi Y, Sasaki S, Hayashi A, Marumo F and Ikeuchi T: Assignment of the genes encoding the human chloride channels, CLCNKA and CLCNKB, to 1p36 and of CLCN3 to 4q32-q33 by in situ hybridization. Genomics. 36:372–374. 1996. View Article : Google Scholar : PubMed/NCBI
15	Lee BH, Cho HY, Lee H, Han KH, Kang HG, Ha IS, Lee JH, Park YS, Shin JI, Lee DY, et al: Genetic basis of Bartter syndrome in Korea. Nephrol Dial Transplant. 27:1516–1521. 2012. View Article : Google Scholar : PubMed/NCBI
16	Friis UG, Stubbe J, Uhrenholt TR, Svenningsen P, Nüsing RM, Skøtt O and Jensen BL: Prostaglandin E2 EP2 and EP4 receptor activation mediates cAMP-dependent hyperpolarization and exocytosis of renin in juxtaglomerular cells. Am J Physiol Renal Physiol. 289:F989–F997. 2005. View Article : Google Scholar : PubMed/NCBI
17	Sun Y, Zhang J, Zhang JQ and Ramires FJ: Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats. Hypertension. 35:1078–1084. 2000. View Article : Google Scholar : PubMed/NCBI
18	Labandeira-Garcia JL, Costa-Besada MA, Labandeira CM, Villar-Cheda B and Rodríguez-Perez AI: Insulin-Like Growth Factor-1 and Neuroinflammation. Front Aging Neurosci. 9:3652017. View Article : Google Scholar : PubMed/NCBI
19	Marra AM, Bobbio E, D'Assante R, Salzano A, Arcopinto M, Bossone E and Cittadini A: Growth Hormone as Biomarker in Heart Failure. Heart Fail Clin. 14:65–74. 2018. View Article : Google Scholar : PubMed/NCBI
20	Wang J, Li YC, Deng M, Jiang HY, Guo LH, Zhou WJ and Ruan B: Serum insulin-like growth factor-1 and its binding protein 3 as prognostic factors for the incidence, progression, and outcome of hepatocellular carcinoma: A systematic review and meta-analysis. Oncotarget. 8:81098–81108. 2017.PubMed/NCBI
21	Buyukcelik M, Keskin M, Kilic BD, Kor Y and Balat A: Bartter syndrome and growth hormone deficiency: Three cases. Pediatr Nephrol. 27:2145–2148. 2012. View Article : Google Scholar : PubMed/NCBI
22	Flyvbjerg A, Dørup I, Everts ME and Orskov H: Evidence that potassium deficiency induces growth retardation through reduced circulating levels of growth hormone and insulin-like growth factor I. Metabolism. 40:769–775. 1991. View Article : Google Scholar : PubMed/NCBI
23	Kackstein K, Teren A, Matsumoto Y, Mangner N, Möbius-Winkler S, Linke A, Schuler G, Punkt K and Adams V: Impact of angiotensin II on skeletal muscle metabolism and function in mice: Contribution of IGF-1, Sirtuin-1 and PGC-1α. Acta Histochem. 115:363–370. 2013. View Article : Google Scholar : PubMed/NCBI
24	Zaika O, Tomilin V, Mamenko M, Bhalla V and Pochynyuk O: New perspective of ClC-Kb/2 Cl-channel physiology in the distal renal tubule. Am J Physiol Renal Physiol. 310:F923–F930. 2016. View Article : Google Scholar : PubMed/NCBI
25	Rinaldi C, Bott LC, Chen KL, Harmison GG, Katsuno M, Sobue G, Pennuto M and Fischbeck KH: Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol Med. 18:1261–1268. 2012. View Article : Google Scholar : PubMed/NCBI
26	Cha EJ, Hwang WM, Yun SR and Park MH: An adult case of Bartter syndrome type III presenting with proteinuria. J Pathol Transl Med. 50:160–164. 2016. View Article : Google Scholar : PubMed/NCBI
27	Schurman SJ, Perlman SA, Sutphen R, Campos A, Garin EH, Cruz DN and Shoemaker LR: Genotype/phenotype observations in African Americans with Bartter syndrome. J Pediatr. 139:105–110. 2001. View Article : Google Scholar : PubMed/NCBI
28	Cheng CJ, Lo YF, Chen JC, Huang CL and Lin SH: Functional severity of CLCNKB mutations correlates with phenotypes in patients with classic Bartter's syndrome. J Physiol. 595:5573–5586. 2017. View Article : Google Scholar : PubMed/NCBI
29	Bettinelli A, Borsa N, Bellantuono R, Syrén ML, Calabrese R, Edefonti A, Komninos J, Santostefano M, Beccaria L, Pela I, et al: Patients with biallelic mutations in the chloride channel gene CLCNKB: Long-term management and outcome. Am J Kidney Dis. 49:91–98. 2007. View Article : Google Scholar : PubMed/NCBI
30	Nozu K, Fu XJ, Nakanishi K, Yoshikawa N, Kaito H, Kanda K, Krol RP, Miyashita R, Kamitsuji H, Kanda S, et al: Molecular analysis of patients with type III Bartter syndrome: Picking up large heterozygous deletions with semiquantitative PCR. Pediatr Res. 62:364–369. 2007. View Article : Google Scholar : PubMed/NCBI
31	Lee JW, Lee J, Heo NJ, Cheong HI and Han JS: Mutations in SLC12A3 and CLCNKB and their correlation with clinical phenotype in patients with Gitelman and Gitelman-like syndrome. J Korean Med Sci. 31:47–54. 2016. View Article : Google Scholar : PubMed/NCBI
32	Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, et al: Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet. 17:171–178. 1997. View Article : Google Scholar : PubMed/NCBI
33	Urbanová M, Reiterová J, Stěkrova J, Lněnická P and Ryšavá R: DNA analysis of renal electrolyte transporter genes among patients suffering from Bartter and Gitelman syndromes: Summary of mutation screening. Folia Biol (Praha). 57:65–73. 2011.PubMed/NCBI
34	Chiang WF and Lin SH, Chan JS and Lin SH: Hypokalemic paralysis in a middle-aged female with classic Bartter syndrome. Clin Nephrol. 81:146–150. 2014. View Article : Google Scholar : PubMed/NCBI
35	Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A, Ruf R, Deschênes G, Antignac C, et al: Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol. 11:1449–1459. 2000.PubMed/NCBI